BackEnsysce Biosciences Overview

Ensysce Biosciences Receivables

Latest receivables for ENSC: $420K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$416811.00
65.41% YoYΔ $-788168.00 vs prior year quarter

Peer trimmed avg / median

Loading

Ensysce Biosciences Receivables History

Loading

Ensysce Biosciences vs. peers: Receivables Comparison

Loading

Ensysce Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ensysce Biosciences (ENSC) FAQ

As of the most recent data (June 2026), ENSC shows a receivables of $420K. That compares with $1.2M in the prior-year period — down 65.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENSC's receivables is now $420K (was $1.2M) — a 65.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ensysce Biosciences is outperforming or lagging.

Tracking ENSC's receivables over time shows whether Ensysce Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $420K That compares with $1.2M in the prior-year period — down 65.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Ensysce Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $420K) with ownership activity and broader fundamentals.

Ensysce Biosciences's receivables is $420K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.